Buchumschlag

Theranostics in surgical oncology

Theranostics is a method where molecules that target surface structures in tumors are coupled with different radioisotopes, allowing them to bind to tumor cells for detection (diagnostic) and elimination (therapeutic). In the case of neuroendocrine tumors (NET), peptides targeting somatostatin recep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stättner, Stefan (VerfasserIn) , Soreide, Kjetil (VerfasserIn) , Hallet, Julie (VerfasserIn) , Grana, Chiara Maria (VerfasserIn) , Partelli, Stefan (VerfasserIn) , Herrmann, Ken (VerfasserIn) , Brandl, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2026
In: European journal of surgical oncology
Year: 2026, Jahrgang: 52, Heft: 1, Pages: 1-8
ISSN:1532-2157
DOI:10.1016/j.ejso.2025.111187
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejso.2025.111187
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0748798325016154
Volltext
Verfasserangaben:S. Stättner, Kjetil Soreide, Julie Hallet, Chiara Maria Grana, Stefan Partelli, Ken Herrmann, Andreas Brandl

MARC

LEADER 00000naa a2200000 c 4500
001 1950581446
003 DE-627
005 20260129105124.0
007 cr uuu---uuuuu
008 260129s2026 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejso.2025.111187  |2 doi 
035 |a (DE-627)1950581446 
035 |a (DE-599)KXP1950581446 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Stättner, Stefan  |e VerfasserIn  |0 (DE-588)1388309041  |0 (DE-627)1950582639  |4 aut 
245 1 0 |a Theranostics in surgical oncology  |c S. Stättner, Kjetil Soreide, Julie Hallet, Chiara Maria Grana, Stefan Partelli, Ken Herrmann, Andreas Brandl 
264 1 |c January 2026 
300 |b Illustrationen 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 13. November 2025, Artikelversion: 15. November 2025 
500 |a Gesehen am 29.01.2026 
520 |a Theranostics is a method where molecules that target surface structures in tumors are coupled with different radioisotopes, allowing them to bind to tumor cells for detection (diagnostic) and elimination (therapeutic). In the case of neuroendocrine tumors (NET), peptides targeting somatostatin receptors (SSTR) are most commonly used for this purpose. These peptides are, for example, coupled with 68Ga for diagnostic and 177Lu for therapeutic purposes. This allows SSTR-positive tumors to be detected with high sensitivity and treated effectively, which is particularly beneficial in cases where surgery (alone) is not feasible. However, theranostic procedures can also be used to guide surgical procedures or - in the context of a neoadjuvant approach - increase resectability. Other therapies currently in development aim to increase antitumor effectiveness or aim to combat tumors which are resistant to other radiopharmaceutical therapies (RPT) using new isotopes and SSTR-targeting peptides or combining RPT with other drugs. Modern radiological diagnostics, as well as the production and use of radiopharmaceuticals, require costly equipment and specialized procedures and are therefore not accessible to most patients around the world. However, the expansion of the repertoire of studied and approved theranostics promises to make these highly effective treatments available to more patients. The following review intends to provide an overview of current questions about theranostics with relevance to surgical oncology. 
650 4 |a For submission 
650 4 |a NET 
650 4 |a Neuroendocrine tumor 
650 4 |a Nuclear medicine 
650 4 |a Oncologic surgery 
650 4 |a Radiopharmaceutic therapy 
650 4 |a Surgical oncology 
650 4 |a Theranostics 
700 1 |a Soreide, Kjetil  |e VerfasserIn  |4 aut 
700 1 |a Hallet, Julie  |e VerfasserIn  |4 aut 
700 1 |a Grana, Chiara Maria  |e VerfasserIn  |4 aut 
700 1 |a Partelli, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Herrmann, Ken  |e VerfasserIn  |4 aut 
700 1 |a Brandl, Andreas  |d 1980-  |e VerfasserIn  |0 (DE-588)140114556  |0 (DE-627)61603122X  |0 (DE-576)31465951X  |4 aut 
773 0 8 |i Enthalten in  |t European journal of surgical oncology  |d Burlington, Mass. : Harcourt, 1995  |g 52(2026), 1 vom: Jan., Artikel-ID 111187, Seite 1-8  |h Online-Ressource  |w (DE-627)320420361  |w (DE-600)2002481-2  |w (DE-576)103746862  |x 1532-2157  |7 nnas  |a Theranostics in surgical oncology 
773 1 8 |g volume:52  |g year:2026  |g number:1  |g month:01  |g elocationid:111187  |g pages:1-8  |g extent:8  |a Theranostics in surgical oncology 
856 4 0 |u https://doi.org/10.1016/j.ejso.2025.111187  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0748798325016154  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260129 
993 |a Article 
994 |a 2026 
998 |g 140114556  |a Brandl, Andreas  |m 140114556:Brandl, Andreas  |d 910000  |d 910200  |d 50000  |e 910000PB140114556  |e 910200PB140114556  |e 50000PB140114556  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 7  |y j 
999 |a KXP-PPN1950581446  |e 4864290962 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Theranostics in surgical oncology","title":"Theranostics in surgical oncology"}],"language":["eng"],"id":{"doi":["10.1016/j.ejso.2025.111187"],"eki":["1950581446"]},"physDesc":[{"noteIll":"Illustrationen","extent":"8 S."}],"relHost":[{"title":[{"title":"European journal of surgical oncology","title_sort":"European journal of surgical oncology"}],"language":["eng"],"part":{"issue":"1","pages":"1-8","extent":"8","text":"52(2026), 1 vom: Jan., Artikel-ID 111187, Seite 1-8","year":"2026","volume":"52"},"pubHistory":["Nachgewiesen 21.1995 -"],"titleAlt":[{"title":"EJSO"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320420361","origin":[{"publisher":"Harcourt","dateIssuedDisp":"1995-","dateIssuedKey":"1995","publisherPlace":"Burlington, Mass."}],"disp":"Theranostics in surgical oncologyEuropean journal of surgical oncology","id":{"zdb":["2002481-2"],"issn":["1532-2157"],"eki":["320420361"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 05.02.20"]}],"note":["Online verfügbar: 13. November 2025, Artikelversion: 15. November 2025","Gesehen am 29.01.2026"],"origin":[{"dateIssuedKey":"2026","dateIssuedDisp":"January 2026"}],"recId":"1950581446","type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Stefan","role":"aut","display":"Stättner, Stefan","family":"Stättner"},{"display":"Soreide, Kjetil","role":"aut","given":"Kjetil","family":"Soreide"},{"display":"Hallet, Julie","role":"aut","given":"Julie","family":"Hallet"},{"given":"Chiara Maria","role":"aut","display":"Grana, Chiara Maria","family":"Grana"},{"given":"Stefan","role":"aut","display":"Partelli, Stefan","family":"Partelli"},{"display":"Herrmann, Ken","role":"aut","given":"Ken","family":"Herrmann"},{"family":"Brandl","display":"Brandl, Andreas","given":"Andreas","role":"aut"}],"name":{"displayForm":["S. Stättner, Kjetil Soreide, Julie Hallet, Chiara Maria Grana, Stefan Partelli, Ken Herrmann, Andreas Brandl"]}} 
SRT |a STAETTNERSTHERANOSTI2026 

Ähnliche Einträge